Using Bacteriophages to Prevent Infections from Pseudomonas aeruginosa in Mice
Author Information
Author(s): Coelho Luiz Felipe Leomil, de Souza Terceti Mateus, Neto Sergio Pereira Lima, Amaral Raíne Piva, dos Santos Ana Luisa Cauvila, Gozzi William Permagnani, de Carvalho Bianca Andrade, da Cunha Gustavo Aparecido, Durante Maria Fernanda Romboli, Sanchietta Lais, Marangoni Giovana Soares, Gabriel Matheus Luca Carotta, Malaquias Luiz Cosme Cotta, Celis Eliana Leonor Hurtado, de Souza Apolinário Giovanna, Araujo Junior João Pessoa, de Oliveira Carine Ervolino, Queiroz Victoria Fulgencio, Magno de Freitas Almeida Gabriel
Primary Institution: Federal University of Alfenas, Brazil
Hypothesis
Can mucosal-adapted bacteriophages prevent infections caused by Pseudomonas aeruginosa?
Conclusion
Mucosal-adapted phage VAC3 effectively protects mice from lethal doses of Pseudomonas aeruginosa.
Supporting Evidence
- Phage VAC3 was more effective in replicating in mucin-exposed Pseudomonas aeruginosa.
- Pre-treatment with VAC3 phage improved survival rates in mice infected with Pseudomonas aeruginosa.
- Histopathological analysis showed less lung damage in VAC3 pre-treated mice compared to controls.
Takeaway
Scientists found that a special virus called phage VAC3 can help protect mice from a harmful germ called Pseudomonas aeruginosa.
Methodology
The study involved isolating two phages from environmental samples and testing their ability to prevent infections in mice.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
C57BL/6 mice were used in the study.
Statistical Information
P-Value
p=0.0002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website